Back to results
US 12,612,469 B2Granted
Fusion polypeptide comprising polypeptide region that can be O-glycosylated
AssigneeLG Chem, Ltd.
InventorsYeonchul Kim, Seung Joo Lee, Jong Uk Koh, Kyuyong Kim, Saem Jung, Young Dok Son
Life of this patent
Estimating the term…
Abstract
Disclosed are a fusion polypeptide comprising a target polypeptide and a hinge region of an immunoglobulin; a pharmaceutical composition containing the fusion polypeptide; and a method for increasing the in vivo period of a target polypeptide, comprising a step of fusing a hinge region of an immunoglobulin with the target polypeptide.
Claims10
A fusion polypeptide comprising the structure of the following formula:
- N′—(Z)n-Y—(Z)m-C′
- in the above formula,
- N′ is the N-terminus of the fusion polypeptide, C′ is the C-terminus of the fusion polypeptide,
- Y is a target polypeptide,
- Z is an O-glycosylatable polypeptide region,
- n is the number of O-glycosylatable polypeptide regions bound to the N-terminus of the target polypeptide, and is an integer of 1, and
- m is the number of O-glycosylatable polypeptide regions bound to the C-terminus of the target polypeptide, and is an integer of 2 or 3,
- wherein each of the O-glycosylatable polypeptide regions is independently selected from the group consisting of:
- (1) a hinge region of Immunoglobulin D (IgD),
- (2) a hinge region of Immunoglobulin A (IgA),
- (3) a polypeptide comprising the amino acid sequence of SEQ ID NO:
- 1,
- (4) a polypeptide comprising 5 or more consecutive amino acids of the amino acid sequence of SEQ ID NO:
- 1 and containing 3 to 7 O-glycosylated residues,
- (5) a polypeptide comprising 34 or more consecutive amino acids of Immunoglobulin D (IgD) and containing the polypeptide of (3) or (4),
- (6) a polypeptide comprising the amino acid sequence of SEQ ID NO:
- 2,
- (7) a polypeptide comprising 8 or more consecutive amino acids of the amino acid sequence of SEQ ID NO:
- 2 and containing 3 to 8 O-glycosylated residues, and
- (8) a polypeptide comprising 19 or more consecutive amino acids of Immunoglobulin A (IgA) and containing the polypeptide of (6) or (7),
- the fusion polypeptide is O-glycosylated, and
- the total number of O-glycans contained in the fusion polypeptide is 13 or more per the target polypeptide.
19 more elements
Dependencies are inferred from the claim text.